Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.72 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.8 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Nov 18
2022
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
2,900
+50.0%
|
$49,300
$17.14 P/Share
|
|
Nov 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$91,732
$17.43 P/Share
|
|
Nov 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 17
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.17 P/Share
|
|
Nov 17
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Nov 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$97,128
$18.52 P/Share
|
|
Nov 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 16
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$337,500
$18.29 P/Share
|
|
Nov 16
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Nov 02
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$102,524
$19.53 P/Share
|
|
Nov 02
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$107,920
$20.03 P/Share
|
|
Nov 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 20
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
29,548
-28.18%
|
$590,960
$20.51 P/Share
|
|
Oct 20
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,548
+34.88%
|
$88,644
$3.0 P/Share
|
|
Oct 19
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
20,452
-22.91%
|
$409,040
$20.23 P/Share
|
|
Oct 19
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,452
+30.74%
|
$61,356
$3.0 P/Share
|
|
Oct 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.79 P/Share
|
|
Oct 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 14
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.79 P/Share
|
|
Oct 14
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.27 P/Share
|
|
Oct 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$32,376
$4.49 P/Share
|
|
Oct 03
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$186,162
$23.17 P/Share
|
|
Oct 03
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$32,376
$4.49 P/Share
|
|
Oct 03
2022
|
Priscilla Kasenchak Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,352
+50.0%
|
-
|
|
Sep 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
10,792
-49.86%
|
$237,424
$22.98 P/Share
|
|
Sep 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,792
+33.27%
|
$43,168
$4.49 P/Share
|
|
Sep 26
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$118,712
$22.62 P/Share
|
|
Sep 26
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Sep 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$186,162
$23.08 P/Share
|
|
Sep 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Sep 08
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
13,490
-32.33%
|
$296,780
$22.79 P/Share
|
|
Sep 08
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,490
+35.66%
|
$53,960
$4.49 P/Share
|
|
Aug 24
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.9 P/Share
|
|
Aug 24
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Aug 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.49 P/Share
|
|
Aug 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Aug 11
2022
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,337,500
-5.51%
|
$272,100,000
$24.35 P/Share
|
|
Aug 10
2022
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,009
+50.0%
|
-
|
|
Aug 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$186,162
$23.96 P/Share
|
|
Aug 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Aug 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$210,444
$26.09 P/Share
|
|
Aug 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Jul 21
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
79,768
-22.28%
|
$2,153,736
$27.5 P/Share
|